Table of Contents
Bioequivalence Assessment of three 0.025% tretinoin gel products: Dermatopharmacokinetic vs. Clinical Trial Methods
Common Goal Best Therapeutic Products
Hypothesis
Bioequivalence
Bioequivalence Q1 Q2 similar
Bioavailability Q1 Q2 different
Tretinoin gel, 0.025%
Bioequivalence Assessment Clinical Efficacy/Safety Acne Trial
Topical Drug Delivery
Adhesive disc
SC Drug Disposition Influence Of Weight Removed On Drug Concentration Gradient
Bioanalytical Assay Validation
Product Dosing: 0.025% Tretinoin Gel
DPK Experimental Design
Product Application Randomization tretinoin gel, 0.025%
BE Study Demographics
Surface Area Considerations Treated Skin Site vs. Adhesive Disc
DPK Bioequivalence tretinoin gel, 0.025%
DPK Bioequivalence Tretinoin
DPK Bioequivalence tretinoin gel, 0.025%
DPK Bioequivalence Isotretinoin
DPK Bioequivalence tretinoin gel, 0.025%
DPK Bioequivalence Total Retinoids
Bioequivalence Assessment of Three 0.025% tretinoin gel products
DPK Method for Bioequivalence Assessment
CONCLUSIONS DPK Method for Bioequivalence Assessment 0.025% tretinoin gel
|